| Sign In to gain access to subscriptions and/or personal tools. |
DOI: 10.1177/000992289803700101 Treatment Options for the Child with Allergic RhinitisDepartment of Pediatrics, University of California, San Diego; Division of Allergy and Immunology, Children's Hospital; Allergy & Asthma Medical Group & Research Center, 9610 Granite Ridge Drive, Suite B, San Diego, CA 92123 Allergic rhinitis is extremely common in pediatric populations. Its symptoms can interfere markedly with everyday life; moreover, untreated allergic rhinitis can predispose patients toward more serious respiratory diseases. Therapy focuses both on reducing the causes (avoidance, immunotherapy) and on controlling manifest symptoms (pharmacotherapy). Antihistamines, decongestants, anticholinergic agents, mast cell stabilizers, and intranasal corticosteroids constitute the pharmacotherapy arsenal. Of these, the intranasal corticosteroids most effectively control the major symptoms; many studies have found that their efficacy in persistent allergic rhinitis is greater than that of decongestants, antihistamines, and cromolyn sodium. Moreover, unlike systemic corticosteroids, they are generally free from adverse side effects. Thus, with appropriate attention to education and formulations most tolerable to children, they should be a wise choice for many pediatric patients.
This article has been cited by other articles:
|
||||||||||||||||||||||||

